Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013544)
◆英語タイトル:Advanced Proteome Therapeutics Corp (APC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013544
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp (APC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Partnerships 13
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Licensing Agreements 15
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Equity Offering 17
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp – Key Competitors 31
Advanced Proteome Therapeutics Corp – Key Employees 32
Advanced Proteome Therapeutics Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Corporate Communications 34
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 34
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 35
Government and Public Interest 36
Apr 15, 2016: Advanced Proteome Therapeutics Embarks Upon a Major Antibody Initiative 36
Product News 37
Nov 29, 2016: APC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC) 37
Other Significant Developments 38
Jul 18, 2016: Advanced Proteome Therapeutics Formulates Strategic Plan Featuring Novel Antibody Program 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp, Key Competitors 31
Advanced Proteome Therapeutics Corp, Key Employees 32
Advanced Proteome Therapeutics Corp, Subsidiaries 33

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析(Advanced Proteome Therapeutics Corp (APC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆